Cover Image
Market Research Report

Global Market Study on Injectable Drug Delivery: Rising Demand for Connected Injectable Drug Delivery Devices being Witnessed

Published by Persistence Market Research Product code 933013
Published Content info 307 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Market Study on Injectable Drug Delivery: Rising Demand for Connected Injectable Drug Delivery Devices being Witnessed
Published: March 9, 2020 Content info: 307 Pages
Description

Scope of the Report

Persistence Market Research (PMR) recently published a market study on the global injectable drug delivery market. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities, restraints, and detailed information about the injectable drug delivery market structure. The market study presents exclusive information about how the injectable drug delivery market will grow during the forecast period of 2019-2029.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compounded annual growth rate (CAGR) are explained in PMR's study in a comprehensive manner. Other information includes pricing analysis, which helps in deep understanding of the pricing details by researchers, suppliers, manufactures, and distributors. Other information contains volume analysis, which includes year-wise growth of the injectable drug delivery market during the forecast period. This information can help readers understand the quantitative growth prospects of the injectable drug delivery market for the forecast period.

The study is relevant for service providers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researcher, shareholders, and industry experts can leverage the information and data presented in PMR's study.

The study also includes statistics as well as facts related to the macroeconomic factors that are impacting developments in the injectable drug delivery market. It also offers actionable insights based on future trends in the injectable drug delivery market. Furthermore, small businesses and new entrants in the injectable drug delivery market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.

Key Questions Answered:

  • Which regions will continue to remain the most profitable regional markets for injectable drug delivery market players?
  • Which factors will induce a change in the growth of the injectable drug delivery market during the assessment period?
  • What are the different opportunities available for emerging players in the injectable drug delivery market?
  • How are supply-side and demand-side drivers impacting the injectable drug delivery market?
  • How will changing trends impact the injectable drug delivery market?
  • How can market players capture the low-hanging opportunities in the injectable drug delivery market in developed regions?
  • Which companies are leading the injectable drug delivery market?
  • What are the winning strategies of stakeholders in the injectable drug delivery market to upscale their position in this landscape?

Research Methodology

In PMR's study, a unique research methodology is utilized to conduct extensive research on the growth of the injectable drug delivery market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the injectable drug delivery market study include statistics from government healthcare organizations, medicinal journals, research journals, press releases, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the injectable drug delivery market, and makes PMR's projection on the growth prospects of the injectable drug delivery market more accurate and reliable.

Table of Contents

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

4. Key Success Factors

  • 4.1. Global Pharmaceutical Outlook
  • 4.2. PEST Analysis
  • 4.3. Key Disease Epidemiology
  • 4.4. Parenteral Drugs Pipeline Assessment
  • 4.5. Regulatory Landscape
  • 4.6. Supply Chain analysis

5. Global Injectable Drug Delivery Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

  • 5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
  • 5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
    • 5.2.1. Y-o-Y Growth Trend Analysis
    • 5.2.2. Absolute $ Opportunity Analysis

6. Key Technologies Assessment

  • 6.1. Under Clinical Development Injectable Drug Delivery Technologies
  • 6.2. Commercialized Injectable Drug Delivery Technologies

7. Market Background

  • 7.1. Macro-Economic Factors
  • 7.2. Forecast Factors - Relevance & Impact
  • 7.3. Market Dynamics
    • 7.3.1. Drivers
    • 7.3.2. Restraints
    • 7.3.3. Opportunity Analysis

8. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 - 2018
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 - 2029
    • 8.3.1. Self-Injectors
      • 8.3.1.1. Single Chamber Self Injectors
      • 8.3.1.2. Dual Chamber Self Injectors
    • 8.3.2. Needle Free Injectors
      • 8.3.2.1. Pre Filled Needle Free Injectors
      • 8.3.2.2. Fill-Able Needle free Injectors
    • 8.3.3. Auto Injectors
      • 8.3.3.1. Prefilled Auto Injectors
      • 8.3.3.2. Fill-Able Auto Injectors
    • 8.3.4. Wearable Injectors
      • 8.3.4.1. Wearable Patch Injectors
      • 8.3.4.2. Off-body Worn Injectors
    • 8.3.5. Insulin Pens
      • 8.3.5.1. Reusable Insulin Pens
      • 8.3.5.2. Disposable Insulin Pens
      • 8.3.5.3. Smart Insulin Pen Caps
  • 8.4. Market Attractiveness Analysis By Product Type

9. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Technology

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Technology, 2014 - 2018
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2019 - 2029
    • 9.3.1. Non-Smart Injectors
    • 9.3.2. Smart Injectors
    • 9.3.3. Artificial Intelligence (AI) and Machine Learning Integrated
    • 9.3.4. Near Field Communication (NFC)
    • 9.3.5. Cloud Computing
    • 9.3.6. Bluetooth
  • 9.4. Market Attractiveness Analysis By Technology

10. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Indication

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014 - 2018
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019 - 2029
    • 10.3.1. Anaphylaxis/ Asthma
    • 10.3.2. Diabetes
    • 10.3.3. Cardiovascular Diseases
    • 10.3.4. Multiple Sclerosis
    • 10.3.5. Rheumatoid Arthritis
    • 10.3.6. Cancer
    • 10.3.7. Trauma and Emergency
    • 10.3.8. Others
  • 10.4. Market Attractiveness Analysis By Indication

11. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Usage

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By Usage, 2014 - 2018
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Usage, 2019 - 2029
    • 11.3.1. Disposable Injectors
    • 11.3.2. Reusable Injectors
  • 11.4. Market Attractiveness Analysis By Usage

12. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 - 2018
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2029
    • 12.3.1. Hospital Pharmacies
    • 12.3.2. Drug Stores
    • 12.3.3. Retail Pharmacies
    • 12.3.4. Online Pharmacies
  • 12.4. Market Attractiveness Analysis By Distribution Channel

13. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018
  • 13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. South Asia
    • 13.3.5. East Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
  • 14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 14.4.1. By Country
      • 14.4.1.1. U.S.
      • 14.4.1.2. Canada
    • 14.4.2. By Product Type
    • 14.4.3. By Technology
    • 14.4.4. By Indication
    • 14.4.5. By Usage
    • 14.4.6. By Distribution Channel
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Product Type
    • 14.5.3. By Technology
    • 14.5.4. By Indication
    • 14.5.5. By Usage
    • 14.5.6. By Distribution Channel

15. Latin America Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
  • 15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 15.4.1. By Country
      • 15.4.1.1. Brazil
      • 15.4.1.2. Argentina
      • 15.4.1.3. Mexico
      • 15.4.1.4. Rest of Latin America
    • 15.4.2. By Product Type
    • 15.4.3. By Technology
    • 15.4.4. By Indication
    • 15.4.5. By Usage
    • 15.4.6. By Distribution Channel
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Product Type
    • 15.5.3. By Technology
    • 15.5.4. By Indication
    • 15.5.5. By Usage
    • 15.5.6. By Distribution Channel

16. Europe Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
  • 16.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
    • 16.4.1. By Country
      • 16.4.1.1. Germany
      • 16.4.1.2. U.K.
      • 16.4.1.3. France
      • 16.4.1.4. France
      • 16.4.1.5. Italy
      • 16.4.1.6. Spain
      • 16.4.1.7. Russia
      • 16.4.1.8. Rest of Europe
    • 16.4.2. By Product Type
    • 16.4.3. By Technology
    • 16.4.4. By Indication
    • 16.4.5. By Usage
    • 16.4.6. By Distribution Channel
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Product Type
    • 16.5.3. By Technology
    • 16.5.4. By Indication
    • 16.5.5. By Usage
    • 16.5.6. By Distribution Channel

17. South Asia Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
  • 17.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
    • 17.4.1. By Country
      • 17.4.1.1. India
      • 17.4.1.2. Thailand
      • 17.4.1.3. Indonesia
      • 17.4.1.4. Malaysia
      • 17.4.1.5. Rest of South Asia
    • 17.4.2. By Product Type
    • 17.4.3. By Technology
    • 17.4.4. By Indication
    • 17.4.5. By Usage
    • 17.4.6. By Distribution Channel
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Product Type
    • 17.5.3. By Technology
    • 17.5.4. By Indication
    • 17.5.5. By Usage
    • 17.5.6. By Distribution Channel

18. East Asia Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
  • 18.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
    • 18.4.1. By Country
      • 18.4.1.1. China
      • 18.4.1.2. Japan
      • 18.4.1.3. South Korea
    • 18.4.2. By Product Type
    • 18.4.3. By Technology
    • 18.4.4. By Indication
    • 18.4.5. By Usage
    • 18.4.6. By Distribution Channel
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Product Type
    • 18.5.3. By Technology
    • 18.5.4. By Indication
    • 18.5.5. By Usage
    • 18.5.6. By Distribution Channel

19. Oceania Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

  • 19.1. Introduction
  • 19.2. Pricing Analysis
  • 19.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
  • 19.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
    • 19.4.1. By Country
      • 19.4.1.1. Australia
      • 19.4.1.2. New Zealand
    • 19.4.2. By Product Type
    • 19.4.3. By Technology
    • 19.4.4. By Indication
    • 19.4.5. By Usage
    • 19.4.6. By Distribution Channel
  • 19.5. Market Attractiveness Analysis
    • 19.5.1. By Country
    • 19.5.2. By Product Type
    • 19.5.3. By Technology
    • 19.5.4. By Indication
    • 19.5.5. By Usage
    • 19.5.6. By Distribution Channel

20. Middle East and Africa Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

  • 20.1. Introduction
  • 20.2. Pricing Analysis
  • 20.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
  • 20.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
    • 20.4.1. By Country
      • 20.4.1.1. GCC Countries
      • 20.4.1.2. Turkey
      • 20.4.1.3. Northern Africa
      • 20.4.1.4. South Africa
      • 20.4.1.5. Rest of Middle East and Africa
    • 20.4.2. By Product Type
    • 20.4.3. By Technology
    • 20.4.4. By Indication
    • 20.4.5. By Usage
    • 20.4.6. By Distribution Channel
  • 20.5. Market Attractiveness Analysis
    • 20.5.1. By Country
    • 20.5.2. By Product Type
    • 20.5.3. By Technology
    • 20.5.4. By Indication
    • 20.5.5. By Usage
    • 20.5.6. By Distribution Channel

21. Key & Emerging Countries Analysis

  • 21.1. U.S. Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
    • 21.1.1. Introduction
    • 21.1.2. Historical Market Size (US$ Mn) & Volume Units Trend Analysis By Market Taxonomy, 2014 - 2018
    • 21.1.3. Market Size (US$ Mn) & Volume Units Forecast By Market Taxonomy, 2019 - 2029
      • 21.1.3.1. By Product Type
      • 21.1.3.2. By Technology
      • 21.1.3.3. By Indication
      • 21.1.3.4. By Usage
      • 21.1.3.5. By Distribution Channel
    • 21.1.4. Market Attractiveness Analysis
  • 21.2. Canada Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.3. Brazil Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.4. Argentina Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.5. Mexico Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.6. Germany Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.7. U. K. Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.8. France Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.9. Italy Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.10. Spain Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.11. BENELUX Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.12. Russia Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.13. China Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.14. Japan Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.15. South Korea Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.16. Australia Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.17. New Zealand Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.18. South Africa Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.19. GCC Countries Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
  • 21.20. Turkey Countries Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

22. Market Structure Analysis

  • 22.1. Market Analysis by Tier of Companies (Injectable Drug Delivery)
  • 22.2. Market Share Analysis of Top Players

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Competition Deep Dive
    • 23.2.1. Eli Lilly and Company
      • 23.2.1.1. Overview
      • 23.2.1.2. Product Portfolio
      • 23.2.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.1.4. Sales Footprint
      • 23.2.1.5. Strategy Overview
        • 23.2.1.5.1. Marketing Strategy
        • 23.2.1.5.2. Product Strategy
        • 23.2.1.5.3. Channel Strategy
    • 23.2.2. Biocon
      • 23.2.2.1. Overview
      • 23.2.2.2. Product Portfolio
      • 23.2.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.2.4. Sales Footprint
      • 23.2.2.5. Strategy Overview
        • 23.2.2.5.1. Marketing Strategy
        • 23.2.2.5.2. Product Strategy
        • 23.2.2.5.3. Channel Strategy
    • 23.2.3. Becton, Dickinson & Company
      • 23.2.3.1. Overview
      • 23.2.3.2. Product Portfolio
      • 23.2.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.3.4. Sales Footprint
      • 23.2.3.5. Strategy Overview
        • 23.2.3.5.1. Marketing Strategy
        • 23.2.3.5.2. Product Strategy
        • 23.2.3.5.3. Channel Strategy
    • 23.2.4. West Pharmaceutical Services, Inc.
      • 23.2.4.1. Overview
      • 23.2.4.2. Product Portfolio
      • 23.2.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.4.4. Sales Footprint
      • 23.2.4.5. Strategy Overview
        • 23.2.4.5.1. Marketing Strategy
        • 23.2.4.5.2. Product Strategy
        • 23.2.4.5.3. Channel Strategy
    • 23.2.5. Johnson & Johnson
      • 23.2.5.1. Overview
      • 23.2.5.2. Product Portfolio
      • 23.2.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.5.4. Sales Footprint
      • 23.2.5.5. Strategy Overview
        • 23.2.5.5.1. Marketing Strategy
        • 23.2.5.5.2. Product Strategy
        • 23.2.5.5.3. Channel Strategy
    • 23.2.6. Antares Pharma
      • 23.2.6.1. Overview
      • 23.2.6.2. Product Portfolio
      • 23.2.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.6.4. Sales Footprint
      • 23.2.6.5. Strategy Overview
        • 23.2.6.5.1. Marketing Strategy
        • 23.2.6.5.2. Product Strategy
        • 23.2.6.5.3. Channel Strategy
    • 23.2.7. AbbVie Inc.
      • 23.2.7.1. Overview
      • 23.2.7.2. Product Portfolio
      • 23.2.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.7.4. Sales Footprint
      • 23.2.7.5. Strategy Overview
        • 23.2.7.5.1. Marketing Strategy
        • 23.2.7.5.2. Product Strategy
        • 23.2.7.5.3. Channel Strategy
    • 23.2.8. Pfizer Inc.
      • 23.2.8.1. Overview
      • 23.2.8.2. Product Portfolio
      • 23.2.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.8.4. Sales Footprint
      • 23.2.8.5. Strategy Overview
        • 23.2.8.5.1. Marketing Strategy
        • 23.2.8.5.2. Product Strategy
        • 23.2.8.5.3. Channel Strategy
    • 23.2.9. Mylan N.V.
      • 23.2.9.1. Overview
      • 23.2.9.2. Product Portfolio
      • 23.2.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.9.4. Sales Footprint
      • 23.2.9.5. Strategy Overview
        • 23.2.9.5.1. Marketing Strategy
        • 23.2.9.5.2. Product Strategy
        • 23.2.9.5.3. Channel Strategy
    • 23.2.10. Vetter Pharma-Fertigung GmbH & Co.KG
      • 23.2.10.1. Overview
      • 23.2.10.2. Product Portfolio
      • 23.2.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.10.4. Sales Footprint
      • 23.2.10.5. Strategy Overview
        • 23.2.10.5.1. Marketing Strategy
        • 23.2.10.5.2. Product Strategy
        • 23.2.10.5.3. Channel Strategy
    • 23.2.11. Emperra GmbH
      • 23.2.11.1. Overview
      • 23.2.11.2. Product Portfolio
      • 23.2.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.11.4. Sales Footprint
      • 23.2.11.5. Strategy Overview
        • 23.2.11.5.1. Marketing Strategy
        • 23.2.11.5.2. Product Strategy
        • 23.2.11.5.3. Channel Strategy
    • 23.2.12. Digital Medics Pty Ltd
      • 23.2.12.1. Overview
      • 23.2.12.2. Product Portfolio
      • 23.2.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.12.4. Sales Footprint
      • 23.2.12.5. Strategy Overview
        • 23.2.12.5.1. Marketing Strategy
        • 23.2.12.5.2. Product Strategy
        • 23.2.12.5.3. Channel Strategy
    • 23.2.13. Enable Injections LLC
      • 23.2.13.1. Overview
      • 23.2.13.2. Product Portfolio
      • 23.2.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.13.4. Sales Footprint
      • 23.2.13.5. Strategy Overview
        • 23.2.13.5.1. Marketing Strategy
        • 23.2.13.5.2. Product Strategy
        • 23.2.13.5.3. Channel Strategy
    • 23.2.14. Insulet corporation
      • 23.2.14.1. Overview
      • 23.2.14.2. Product Portfolio
      • 23.2.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.14.4. Sales Footprint
      • 23.2.14.5. Strategy Overview
        • 23.2.14.5.1. Marketing Strategy
        • 23.2.14.5.2. Product Strategy
        • 23.2.14.5.3. Channel Strategy
    • 23.2.15. Consort Medical Plc
      • 23.2.15.1. Overview
      • 23.2.15.2. Product Portfolio
      • 23.2.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.15.4. Sales Footprint
      • 23.2.15.5. Strategy Overview
        • 23.2.15.5.1. Marketing Strategy
        • 23.2.15.5.2. Product Strategy
        • 23.2.15.5.3. Channel Strategy
    • 23.2.16. Diabnext
      • 23.2.16.1. Overview
      • 23.2.16.2. Product Portfolio
      • 23.2.16.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.16.4. Sales Footprint
      • 23.2.16.5. Strategy Overview
        • 23.2.16.5.1. Marketing Strategy
        • 23.2.16.5.2. Product Strategy
        • 23.2.16.5.3. Channel Strategy
    • 23.2.17. Diamesco Co., Ltd
      • 23.2.17.1. Overview
      • 23.2.17.2. Product Portfolio
      • 23.2.17.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.17.4. Sales Footprint
      • 23.2.17.5. Strategy Overview
        • 23.2.17.5.1. Marketing Strategy
        • 23.2.17.5.2. Product Strategy
        • 23.2.17.5.3. Channel Strategy
    • 23.2.18. SCHOTT AG
      • 23.2.18.1. Overview
      • 23.2.18.2. Product Portfolio
      • 23.2.18.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.18.4. Sales Footprint
      • 23.2.18.5. Strategy Overview
        • 23.2.18.5.1. Marketing Strategy
        • 23.2.18.5.2. Product Strategy
        • 23.2.18.5.3. Channel Strategy
    • 23.2.19. SiO2 Medical Products
      • 23.2.19.1. Overview
      • 23.2.19.2. Product Portfolio
      • 23.2.19.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.19.4. Sales Footprint
      • 23.2.19.5. Strategy Overview
        • 23.2.19.5.1. Marketing Strategy
        • 23.2.19.5.2. Product Strategy
        • 23.2.19.5.3. Channel Strategy
    • 23.2.20. Integrity Bio, Inc.
      • 23.2.20.1. Overview
      • 23.2.20.2. Product Portfolio
      • 23.2.20.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.20.4. Sales Footprint
      • 23.2.20.5. Strategy Overview
        • 23.2.20.5.1. Marketing Strategy
        • 23.2.20.5.2. Product Strategy
        • 23.2.20.5.3. Channel Strategy
    • 23.2.21. Wilhelm Haselmeier GmbH & Co. KG
      • 23.2.21.1. Overview
      • 23.2.21.2. Product Portfolio
      • 23.2.21.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.21.4. Sales Footprint
      • 23.2.21.5. Strategy Overview
        • 23.2.21.5.1. Marketing Strategy
        • 23.2.21.5.2. Product Strategy
        • 23.2.21.5.3. Channel Strategy
    • 23.2.22. Tandem Diabetes Care
      • 23.2.22.1. Overview
      • 23.2.22.2. Product Portfolio
      • 23.2.22.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.22.4. Sales Footprint
      • 23.2.22.5. Strategy Overview
        • 23.2.22.5.1. Marketing Strategy
        • 23.2.22.5.2. Product Strategy
        • 23.2.22.5.3. Channel Strategy
    • 23.2.23. Sanofi S.A.
      • 23.2.23.1. Overview
      • 23.2.23.2. Product Portfolio
      • 23.2.23.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.23.4. Sales Footprint
      • 23.2.23.5. Strategy Overview
        • 23.2.23.5.1. Marketing Strategy
        • 23.2.23.5.2. Product Strategy
        • 23.2.23.5.3. Channel Strategy
    • 23.2.24. Companion Medical Inc.
      • 23.2.24.1. Overview
      • 23.2.24.2. Product Portfolio
      • 23.2.24.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.24.4. Sales Footprint
      • 23.2.24.5. Strategy Overview
        • 23.2.24.5.1. Marketing Strategy
        • 23.2.24.5.2. Product Strategy
        • 23.2.24.5.3. Channel Strategy
    • 23.2.25. Ypsomed
      • 23.2.25.1. Overview
      • 23.2.25.2. Product Portfolio
      • 23.2.25.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.25.4. Sales Footprint
      • 23.2.25.5. Strategy Overview
        • 23.2.25.5.1. Marketing Strategy
        • 23.2.25.5.2. Product Strategy
        • 23.2.25.5.3. Channel Strategy
    • 23.2.26. Hoffman - La Roche Ltd.
      • 23.2.26.1. Overview
      • 23.2.26.2. Product Portfolio
      • 23.2.26.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.26.4. Sales Footprint
      • 23.2.26.5. Strategy Overview
        • 23.2.26.5.1. Marketing Strategy
        • 23.2.26.5.2. Product Strategy
        • 23.2.26.5.3. Channel Strategy
    • 23.2.27. Novo Nordisk A/S
      • 23.2.27.1. Overview
      • 23.2.27.2. Product Portfolio
      • 23.2.27.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.27.4. Sales Footprint
      • 23.2.27.5. Strategy Overview
        • 23.2.27.5.1. Marketing Strategy
        • 23.2.27.5.2. Product Strategy
        • 23.2.27.5.3. Channel Strategy
    • 23.2.28. Medtronic Plc.
      • 23.2.28.1. Overview
      • 23.2.28.2. Product Portfolio
      • 23.2.28.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.2.28.4. Sales Footprint
      • 23.2.28.5. Strategy Overview
        • 23.2.28.5.1. Marketing Strategy
        • 23.2.28.5.2. Product Strategy
        • 23.2.28.5.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

List of Tables

  • Table 02: Global Injectable Drug Delivery Market Value (US$ Bn) Analysis 2014-2018 and Forecast 2019-2029, by Technology
  • Table 03: Global Injectable Drug Delivery Market Value (US$ Bn) Analysis 2014-2018 and Forecast 2019-2029, by Usage
  • Table 04: Global Injectable Drug Delivery Market Value (US$ Bn) Analysis 2014-2018 and Forecast 2019-2029, by Indication
  • Table 05: Global Injectable Drug Delivery Market Value (US$ Bn) Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
  • Table 06: Global Injectable Drug Delivery Market Value (US$ Bn) Analysis 2014-2018 and Forecast 2019-2029, by Region
  • Table 07: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Country
  • Table 08: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Product Type
  • Table 09: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Technology
  • Table 10: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Usage
  • Table 11: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Indication
  • Table 12: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
  • Table 13: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Country
  • Table 14: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Product Type
  • Table 15: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Technology
  • Table 16: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Usage
  • Table 17: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Indication
  • Table 18: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-018 and Forecast 2019-2029, by Distribution Channel
  • Table 19: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Country
  • Table 20: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Product Type
  • Table 21: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Technology
  • Table 22: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Usage

  • Table 23: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Indication
  • Table 24: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
  • Table 25: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Country
  • Table 26: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Product Type
  • Table 27: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Technology
  • Table 28: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Usage
  • Table 29: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Indication
  • Table 30: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

  • Table 31: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Country
  • Table 32: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Product Type
  • Table 33: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Technology
  • Table 34: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Usage
  • Table 35: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Indication
  • Table 36: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
  • Table 37: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Country
  • Table 38: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Product Type
  • Table 39: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Technology
  • Table 40: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Usage
  • Table 41: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Indication
  • Table 42: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
  • Table 43: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Country
  • Table 44: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Product Type
  • Table 45: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Technology
  • Table 46: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Usage
  • Table 47: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Indication
  • Table 48: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

List of Figures

  • Figure 01: Injectable Drug Delivery Market Value Analysis and Forecast 2019 - 2029 (US$ Mn)
  • Figure 02: Injectable Drug Delivery Market Value (US$ Mn), 2014 - 2018
  • Figure 03: Injectable Drug Delivery Market Absolute $ Opportunity (US$ Mn), 2018-2029
  • Figure 04: Global Injectable Drug Delivery Market Share Analysis (%) by Product Type, 2018 & 2029
  • Figure 05: Global Injectable Drug Delivery Market Y-o-Y Growth (%) by Product Type, 2020-2029
  • Figure 06: Global Injectable Drug Delivery Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 07: Global Injectable Drug Delivery Market Share Analysis (%) by Technology, 2018 & 2029
  • Figure 08: Global Injectable Drug Delivery Market Y-o-Y Growth (%) by Technology, 2020-2029
  • Figure 09: Global Injectable Drug Delivery Market Attractiveness Analysis by Technology, 2019-2029
  • Figure 10: Global Injectable Drug Delivery Market Share Analysis (%) by Usage, 2018 & 2029
  • Figure 11: Global Injectable Drug Delivery Market Y-o-Y Growth (%) by Usage, 2020-2029
  • Figure 12: Global Injectable Drug Delivery Market Attractiveness Analysis by Usage, 2019-2029
  • Figure 13: Global Injectable Drug Delivery Market Share Analysis (%) by Indication, 2018 & 2029
  • Figure 14: Global Injectable Drug Delivery Market Y-o-Y Growth (%) by Indication, 2020-2029
  • Figure 15: Global Injectable Drug Delivery Market Attractiveness Analysis by Indication, 2019-2029
  • Figure 16: Global Injectable Drug Delivery Market Share Analysis (%) by Distribution Channel, 2018 & 2029
  • Figure 17: Global Injectable Drug Delivery Market Y-o-Y Growth (%) by Distribution Channel, 2020-2029
  • Figure 18: Global Injectable Drug Delivery Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 19: Global Injectable Drug Delivery Market Share Analysis (%) by Region, 2018 & 2029
  • Figure 20: Global Injectable Drug Delivery Market Y-o-Y Growth (%) by Region, 2020-2029
  • Figure 21: Global Injectable Drug Delivery Market Attractiveness Analysis by Region on, 2019-2029
  • Figure 22: North America Injectable Drug Delivery Market Value (US$ Mn), 2014 - 2018
  • Figure 23: North America Injectable Drug Delivery Market Value (US$ Mn) Forecast, 2018-2029
  • Figure 24: North America Injectable Drug Delivery Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 25: North America Injectable Drug Delivery Market Attractiveness Analysis by Country, 2019-2029
  • Figure 26: North America Injectable Drug Delivery Market Attractiveness Analysis by Technology, 2019-2029
  • Figure 27: North America Injectable Drug Delivery Market Attractiveness Analysis by Usage, 2019-2029
  • Figure 28: North America Injectable Drug Delivery Market Attractiveness Analysis by Indication, 2019-2029
  • Figure 29: North America Injectable Drug Delivery Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 30: Latin America Injectable Drug Delivery Market Value (US$ Mn), 2014 - 2018
  • Figure 31: Latin America Injectable Drug Delivery Market Value (US$ Mn) Forecast, 2018-2029
  • Figure 32: Latin America Injectable Drug Delivery Market Attractiveness Analysis byProduct Type, 2019-2029
  • Figure 33: Latin America Injectable Drug Delivery Market Attractiveness Analysis by Country, 2019-2029
  • Figure 34: Latin America Injectable Drug Delivery Market Attractiveness Analysis by Technology, 2019-2029
  • Figure 35: Latin America Injectable Drug Delivery Market Attractiveness Analysis by Usage, 2019-2029
  • Figure 36: Latin America Injectable Drug Delivery Market Attractiveness Analysis by Indication, 2019-2029
  • Figure 37: Latin America Injectable Drug Delivery Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 38: Europe Injectable Drug Delivery Market Value (US$ Mn), 2014 - 2018
  • Figure 39: Europe Injectable Drug Delivery Market Value (US$ Mn) Forecast, 2018-2029Figure
  • Figure 40: Europe Injectable Drug Delivery Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 41: Europe Injectable Drug Delivery Market Attractiveness Analysis by Country, 2019-2029
  • Figure 42: Europe Injectable Drug Delivery Market Attractiveness Analysis by Technology, 2019-2029
  • Figure 43: Europe Injectable Drug Delivery Market Attractiveness Analysis by Usage, 2019-2029
  • Figure 44: Europe Injectable Drug Delivery Market Attractiveness Analysis by Indication, 2019-2029
  • Figure 45: Europe Injectable Drug Delivery Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 46: South Asia Injectable Drug Delivery Market Value (US$ Mn), 2014 - 2018
  • Figure 47: South Asia Injectable Drug Delivery Market Value (US$ Mn) Forecast, 2018-2029
  • Figure 48: South Asia Injectable Drug Delivery Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 49: South Asia Injectable Drug Delivery Market Attractiveness Analysis by Country, 2019-2029
  • Figure 50: South Asia Injectable Drug Delivery Market Attractiveness Analysis by Technology, 2019-2029
  • Figure 51: South Asia Injectable Drug Delivery Market Attractiveness Analysis by Usage, 2019-2029
  • Figure 52: South Asia Injectable Drug Delivery Market Attractiveness Analysis by Indication, 2019-2029
  • Figure 53: South Asia Injectable Drug Delivery Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 54: East Asia Injectable Drug Delivery Market Value (US$ Mn), 2014 - 2018
  • Figure 55: East Asia Injectable Drug Delivery Market Value (US$ Mn) Forecast, 2018-2029
  • Figure 56: East Asia Injectable Drug Delivery Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 57: East Asia Injectable Drug Delivery Market Attractiveness Analysis by Country, 2019-2029
  • Figure 58: East Asia Injectable Drug Delivery Market Attractiveness Analysis by Technology, 2019-2029
  • Figure 59: East Asia Injectable Drug Delivery Market Attractiveness Analysis by Usage, 2019-2029
  • Figure 60: East Asia Injectable Drug Delivery Market Attractiveness Analysis by Indication, 2019-2029
  • Figure 61: East Asia Injectable Drug Delivery Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 62: Oceania Injectable Drug Delivery Market Value (US$ Mn), 2014 - 2018
  • Figure 63: Oceania Injectable Drug Delivery Market Value (US$ Mn) Forecast, 2018-2029
  • Figure 64: Oceania Injectable Drug Delivery Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 65: Oceania Injectable Drug Delivery Market Attractiveness Analysis by Country, 2019-2029
  • Figure 66: Oceania Injectable Drug Delivery Market Attractiveness Analysis by Technology, 2019-2029
  • Figure 67: Oceania Injectable Drug Delivery Market Attractiveness Analysis by Usage, 2019-2029
  • Figure 68: Oceania Injectable Drug Delivery Market Attractiveness Analysis by Indication, 2019-2029
  • Figure 69: Oceania Injectable Drug Delivery Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 70: MEA Injectable Drug Delivery Market Value (US$ Mn), 2014 - 2018
  • Figure 71: MEA Injectable Drug Delivery Market Value (US$ Mn) Forecast, 2018-2029Figure 72: MEA Injectable Drug Delivery Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 73: MEA Injectable Drug Delivery Market Attractiveness Analysis by Country, 2019-2029
  • Figure 74: MEA Injectable Drug Delivery Market Attractiveness Analysis by Technology, 2019-2029
  • Figure 75: MEA Injectable Drug Delivery Market Attractiveness Analysis by Usage, 2019-2029
  • Figure 76: MEA Injectable Drug Delivery Market Attractiveness Analysis by Indication, 2019-2029
  • Figure 77: MEA Injectable Drug Delivery Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 78: U.S. Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 79: U.S. Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 80: U.S. Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 81: U.S. Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 82: U.S. Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 83: Canada Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 84: Canada Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 85: Canada Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 86: Canada Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 87: Canada Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 88: Mexico Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 89: Mexico Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 90: Mexico Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 91: Mexico Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 92: Mexico Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 93: Brazil Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 94: Brazil Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 95: Brazil Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 96: Brazil Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 97: Brazil Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 98: Argentina Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 99: Argentina Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 100: Argentina Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 101: Argentina Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 102: Argentina Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 103: Germany Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 104: Germany Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 105: Germany Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 106: Germany Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 107: Germany Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 108: Italy Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 109: Italy Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 110: Italy Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 111: Italy Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 112: Italy Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 113: France Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 114: France Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 115: France Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 116: France Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 117: France Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 118: U.K. Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 119: U.K. Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 120: U.K. Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 121: U.K. Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 122: U.K. Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 123: Spain Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 124: Spain Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 125: Spain Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 126: Spain Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 127: Spain Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 128: BENELUX Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 129: BENELUX Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 130: BENELUX Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 131: BENELUX Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 132: BENELUX Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 133: Russia Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 134: Russia Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 135: Russia Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 136: Russia Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 137: Russia Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 138: India Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 139: India Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 140: India Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 141: India Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 142: India Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 143: Thailand Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 144: Thailand Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 145: Thailand Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 146: Thailand Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 147: Thailand Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 148: Malaysia Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 149: Malaysia Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 150: Malaysia Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 151: Malaysia Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 152: Malaysia Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 153: Indonesia Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 154: Indonesia Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 155: Indonesia Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 156: Indonesia Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 157: Indonesia Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 158: China Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 159: China Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 160: China Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 161: China Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 162: China Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 163: Japan Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 164: Japan Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 165: Japan Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 166: Japan Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 167: Japan Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 168: South Korea Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 169: South Korea Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 170: South Korea Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 171: South Korea Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 172: South Korea Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 173: Australia Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 174: Australia Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 175: Australia Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 176: Australia Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 177: Australia Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 178: New Zealand Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 179: New Zealand Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 180: New Zealand Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 181: New Zealand Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 182: New Zealand Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 183: GCC Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 184: GCC Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 185: GCC Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 186: GCC Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 187: GCC Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 188: South Africa Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 189: South Africa Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 190: South Africa Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 191: South Africa Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 192: South Africa Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
  • Figure 193: Turkey Injectable Drug Delivery Market Share Analysis (%), by Technology, 2018
  • Figure 194: Turkey Injectable Drug Delivery Market Share Analysis (%), By, Product Type, 2018 & 2029
  • Figure 195: Turkey Injectable Drug Delivery Market Share Analysis (%), by Usage, 2018
  • Figure 196: Turkey Injectable Drug Delivery Market Share Analysis (%), by Distribution Channel, 2018
  • Figure 197: Turkey Injectable Drug Delivery Market Share Analysis (%), by Indication, 2018
Back to Top